Insurer competition and negotiated hospital prices: what new transparency-based research shows

A new peer-reviewed study analyzes hospital-posted negotiated rates for elective hospital-based procedures and finds that markets with more insurer competition tend to have lower negotiated prices, using data released under the Hospital Price Transparency Rule as the primary source. The results speak directly to ongoing policy debates about whether public price files capture payer-provider bargaining power and how competition shapes commercial rates for common services (study, ScienceDirect; paywalled), (CMS Hospital Price Transparency final rule, 2019).

Key findings

  • Higher insurer competition in a market is associated with lower negotiated prices for elective hospital-based procedures, consistent with bargaining theory and prior structural evidence on insurer-provider negotiations (study), (Ho and Lee, Econometrica, 2017).
  • The magnitude of this association varies by region and by hospital market concentration, with more pronounced effects where hospitals have less market power relative to payers (study), (RWJF synthesis on hospital consolidation).
  • Hospital price transparency files can reflect payer-provider bargaining dynamics when linked to market structure measures, though data quality and completeness remain uneven across facilities and time (study), (GAO, 2023).
  • Findings are most relevant to commercial plans that negotiate rates; the rule requires hospitals to publish payer-specific negotiated charges and cash prices for all items and services in a machine-readable file since January 1, 2021 (CMS HPT final rule).
  • Linking hospital files with independent indicators of insurer market concentration, such as HHI-based profiles, enables systematic assessment of whether competition disciplines prices (study), (AMA insurer competition report, overview).

Context & methods

The authors compile hospital-reported payer-specific negotiated prices disclosed under the Hospital Price Transparency Rule and link them to measures of insurer market structure at the local level. They focus on elective hospital-based procedures with substantial price dispersion across markets and plans, and estimate associations controlling for hospital fixed effects, procedure type, regional cost factors, and payer mix to isolate competitive effects on negotiated rates (study).

Under federal rules, hospitals must disclose a machine-readable file listing gross charges, discounted cash prices, and payer-specific negotiated charges; these data underpin the study’s hospital-level price measures (CMS HPT final rule). For the insurer side, commonly used market concentration metrics include HHI derived from enrollment shares, as profiled in national surveys of commercial insurer competition (AMA insurer competition report, overview).

Limitations flagged by the authors and federal oversight bodies include incomplete or inconsistent hospital files, variable standardization across facilities, and the cross-sectional nature of many early analyses, which complicates causal interpretation and trend analysis (study), (GAO, 2023). CMS has moved to tighten display and data element standards to improve comparability over time (CMS CY2024 OPPS/ASC fact sheet).

Implications

  • Consumers: In markets with more competing insurers, negotiated rates for elective services tend to be lower on average, but out-of-pocket costs still depend on benefit design and cost-sharing. Consumers can also consult plan-specific price estimates via Transparency in Coverage consumer tools required since 2023 (CMS TiC final rule).
  • Payers: Competitive pressure appears to discipline negotiated prices. Payers can benchmark contracted rates using both hospital files and payer-posted TiC machine-readable files to assess relative positioning across markets and procedures (CMS Health Plan Price Transparency).
  • Providers: Hospitals in concentrated markets retain pricing leverage; where insurer competition is robust, providers may face stronger countervailing power at the negotiating table, particularly for shoppable elective services (Ho and Lee, 2017), (RWJF synthesis).
  • Regulators: Linking transparency datasets with market structure indicators can help target oversight, merger review, and compliance priorities. CMS has emphasized standardization and enforcement to improve auditability of hospital files and downstream utility for researchers and consumers (CMS CY2024 OPPS/ASC fact sheet), (GAO, 2023).

What to watch next

  • Data quality: Uptake of CMS’s standardized data elements and templates in 2024 to 2025 and how much they reduce missingness and variability across hospital files (CMS CY2024 OPPS/ASC fact sheet).
  • Cross-validation: Replication of findings using payer-posted Transparency in Coverage machine-readable files to test whether insurer competition shows similar price effects across networks and plan types (CMS Health Plan Price Transparency).
  • Market structure: Annual shifts in insurer concentration and entry/exit dynamics tracked by national insurer competition reports and their association with negotiated hospital prices (AMA insurer competition report, overview).
  • Policy changes: State and federal actions on consolidation, antitrust thresholds, or network adequacy that may alter bargaining dynamics and price dispersion (DOJ/FTC Merger Guidelines, 2023).

Sources & further reading